{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:51:54Z","timestamp":1767203514287,"version":"build-2238731810"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR Foundation","doi-asserted-by":"publisher","award":["143288"],"award-info":[{"award-number":["143288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancers are one of the most prevalent tumour types worldwide and, despite the emergence of targeted and biologic therapies, have among the highest mortality rates. The Personalized OncoGenomics (POG) program at BC Cancer performs whole genome and transcriptome analysis (WGTA) to identify specific alterations in an individual\u2019s cancer that may be most effectively targeted. Informed using WGTA, a patient with advanced mismatch repair-deficient colorectal cancer was treated with the antihypertensive drug irbesartan and experienced a profound and durable response. We describe the subsequent relapse of this patient and potential mechanisms of response using WGTA and multiplex immunohistochemistry (m-IHC) profiling of biopsies before and after treatment from the same metastatic site of the L3 spine. We did not observe marked differences in the genomic landscape before and after treatment. Analyses revealed an increase in immune signalling and infiltrating immune cells, particularly CD8+ T cells, in the relapsed tumour. These results indicate that the observed anti-tumour response to irbesartan may have been due to an activated immune response. Determining whether there may be other cancer contexts in which irbesartan may be similarly valuable will require additional studies.<\/jats:p>","DOI":"10.3390\/ijms24065869","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T04:33:31Z","timestamp":1679286811000},"page":"5869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study"],"prefix":"10.3390","volume":"24","author":[{"given":"E.","family":"Titmuss","sequence":"first","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Milne","sequence":"additional","affiliation":[{"name":"Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Topham","sequence":"additional","affiliation":[{"name":"Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brown","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kalloger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Corbett","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mungall","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-2742","authenticated-orcid":false,"given":"A.","family":"Mungall","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Holt","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-2208","authenticated-orcid":false,"given":"S.","family":"Jones","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Laskin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7146-7175","authenticated-orcid":false,"given":"M.","family":"Marra","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sawicki, T., Ruszkowska, M., Danielewicz, A., Nied\u017awiedzka, E., Ar\u0142ukowicz, T., and Przyby\u0142owicz, K.E. (2021). A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13.","DOI":"10.3390\/cancers13092025"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3748\/wjg.v23.i26.4675","article-title":"Present and future of metastatic colorectal cancer treatment: A review of new candidate targets","volume":"23","author":"Martini","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2252244","DOI":"10.1001\/jamanetworkopen.2022.52244","article-title":"Comparative Effectiveness of Immune Checkpoint Inhibitors vs. Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden","volume":"6","author":"Graf","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1078-0432.CCR-20-1163","article-title":"Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors","volume":"27","author":"Pender","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/gb-2010-11-8-r82","article-title":"Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors","volume":"11","author":"Jones","year":"2010","journal-title":"Genome Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s43018-020-0050-6","article-title":"Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes","volume":"1","author":"Pleasance","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdw060","article-title":"Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer","volume":"27","author":"Jones","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-19-0191","article-title":"NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma","volume":"25","author":"Jones","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a004713","DOI":"10.1101\/mcs.a004713","article-title":"Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant","volume":"6","author":"Majounie","year":"2019","journal-title":"Mol. Case Stud."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"a002626","DOI":"10.1101\/mcs.a002626","article-title":"Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: Using whole-genome sequencing to inform clinical decision-making","volume":"4","author":"Chahal","year":"2018","journal-title":"Mol. Case Stud."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: A double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"ref_15","unstructured":"FDA (2020, June 17). FDA Approves Pembrolizumab for Adults and Children with TMB-H Solid Tumors, Available online: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-pembrolizumab-adults-and-children-tmb-h-solid-tumors."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: Statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2012.11.021","article-title":"A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8+ T Cells","volume":"38","author":"Ladell","year":"2013","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: Immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.annonc.2020.07.002","article-title":"The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) \u226510: A decision centered on empowering patients and their physicians","volume":"31","author":"Subbiah","year":"2020","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_24","first-page":"32","article-title":"Costs of Extended Use of the Immune Checkpoint Inhibitors in First-line Non-Small Cell Lung Cancer","volume":"7","author":"Guirgis","year":"2021","journal-title":"J. Clincal Pathw."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1593\/tlo.13346","article-title":"Exposure to ACEI\/ARB and \u03b2-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer","volume":"6","author":"Engineer","year":"2013","journal-title":"Transl. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.2337\/diabetes.54.12.3442","article-title":"Molecular Characterization of New Selective Peroxisome Proliferator-Activated Receptor Modulators with Angiotensin Receptor Blocking Activity","volume":"54","author":"Schupp","year":"2005","journal-title":"Diabetes"},{"key":"ref_28","first-page":"3295","article-title":"Irbesartan attenuates TNF-\u03b1-induced ICAM-1, VCAM-1, and E-selectin expression through suppression of NF-\u03baB pathway in HUVECs","volume":"19","author":"Jiang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_29","unstructured":"Cardoso, B.K., Tomaz, E., Viseu, R., and Inacio, F. (2016). P132 Late-onset manculopapular rash to irbesartan. Presented at the Clinical and Translational Allergy."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1101\/gr.137570.112","article-title":"Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer","volume":"22","author":"Ha","year":"2012","journal-title":"Genome Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bioinformatics\/btr629","article-title":"Feature-based classifiers for somatic mutation detection in tumour\u2013normal paired sequencing data","volume":"28","author":"Ding","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: Accurate somatic small-variant calling from sequenced tumor\u2013normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-022-01348-z","article-title":"TMBur: A Distributable Tumor Mutation Burden Approach for Whole Genome Sequencing (in Preparation)","volume":"15","author":"Titmuss","year":"2022","journal-title":"BMC Med. Genom."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Butterfield, Y.S., Kreitzman, M., Thiessen, N., Corbett, R.D., Li, Y., Pang, J., Ma, Y.P., Jones, S.J., and Birol, I. (2014). JAGuaR: Junction Alignments to Genome for RNA-Seq Reads. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102398"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","article-title":"Meta and Orthogonal Integration of Influenza \u201cOMICs\u201d Data Defines a Role for UBR4 in Virus Budding","volume":"18","author":"Tripathi","year":"2015","journal-title":"Cell Host Microbe."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: Tool for The Unification of Biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"The Gene Ontology Consortium (2017). Expansion of The Gene Ontology Knowledgebase and Resources. Nucleic Acids Res., 45, D331\u2013D338.","DOI":"10.1093\/nar\/gkw1108"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","article-title":"OptiType: Precision HLA Typing From Next-generation Sequencing Data","volume":"30","author":"Szolek","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: Software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shugay, M., Bagaev, D.V., Turchaninova, M.A., Bolotin, D.A., Britanova, O.V., Putintseva, E.V., Pogorelyy, M.V., Nazarov, V.I., Zvyagin, I.V., and Kirgizova, V.I. (2015). VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004503"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nazarov, V.I., Pogorelyy, M.V., Komech, E.A., Zvyagin, I.V., Bolotin, D.A., Shugay, M., Chudakov, D.M., Lebedev, Y.B., and Mamedov, I.Z. (2015). tcR: An R Package for T Cell Receptor Repertoire Advanced Data Analysis. BMC Bioinform., 16.","DOI":"10.1186\/s12859-015-0613-1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gkx760","article-title":"VDJdb: A Curated Database of T-Cell Receptor Sequences with Known Antigen Specificity","volume":"46","author":"Shugay","year":"2018","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.3390\/ijms252212225","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T13:49:06Z","timestamp":1754228946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24065869"],"URL":"https:\/\/doi.org\/10.3390\/ijms24065869","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}